Explore By Subject Area   
Return Home
Menu

Lead Editorial

What CMOs Need to Know about the Pharma Partnership Diligence Process

What CMOs Need to Know about the Pharma Partnership Diligence Process

With experience on both the pharma and biotech side of partnerships, Jeremy Sokolove, CMO of Odyssey Therapeutics, discusses how these deals are evaluated and what CMOs can do to ensure success throughout the process.

Read More

Featured Editorial

How MIT Developed Invisible Remote Monitoring to Enhance Research

Read More

A CEO’s Perspective on the Skills Needed to Succeed as a CMO with a Translational Company

Read More

Roche Moves from Patient-Centricity to Patient-Inclusivity: Inside and Outside the Company

Read More

CEO of Locust Walk on Biotech Financial Trends

Read More

Dr Carolyn Bertozzi Shares Her Award-Winning Work in IO and Her Hope for Greater Diversity in the Field

Read More

Editorial by Category

Clinical Trial Operations

View All
Aitia’s CEO Wants You to Use AI to Do More than Designing Drugs Against Known Validated Targets
Aitia’s CEO Wants You to Use AI to Do More than Designing Drugs Against Known Validated Targets
How Regeneron Is Applying Innovation to Modernize Clinical Trials
How Regeneron Is Applying Innovation to Modernize Clinical Trials
The Role of Generative AI in Making Better Immuno-Oncology Therapeutics
The Role of Generative AI in Making Better Immuno-Oncology Therapeutics
How J&J Innovative Medicine Applies Innovative Trial Designs for Patient Flexibility and Efficient Drug Development
How J&J Innovative Medicine Applies Innovative Trial Designs for Patient Flexibility and Efficient Drug Development

Immuno-Oncology and Cell Therapy

View All
Moffitt Cancer Center CEO Dr Patrick Hwu on CAR T, TILs and Tracking Patient Outcomes
Moffitt Cancer Center CEO Dr Patrick Hwu on CAR T, TILs and Tracking Patient Outcomes
The Role of Generative AI in Making Better Immuno-Oncology Therapeutics
The Role of Generative AI in Making Better Immuno-Oncology Therapeutics
Pushing IO and Cell Therapy Further at Astellas
Pushing IO and Cell Therapy Further at Astellas
​​​​​​​Reporting on the Latest Advancements and Data in IO: Immuno-Oncology 360° 2024 Recap
​​​​​​​Reporting on the Latest Advancements and Data in IO: Immuno-Oncology 360° 2024 Recap

Drug Delivery

View All
How Genentech Makes Device Decisions to De-Risk Combination Product Development
How Genentech Makes Device Decisions to De-Risk Combination Product Development
Novel Approaches to Achieve Long-Acting Formulations for Biologics
Novel Approaches to Achieve Long-Acting Formulations for Biologics
Working with Outsourcers to Get Combination Products to Market Faster
Working with Outsourcers to Get Combination Products to Market Faster
PODD 2023: The Future of Digital Technology in the Connected Device Space
PODD 2023: The Future of Digital Technology in the Connected Device Space

Patients as Partners in Clinical Research and Patient Access

View All
​​​​​​​Demonstrating How Patient Engagement Gets Done: Patients as Partners in Clinical Research 2024 Recap
​​​​​​​Demonstrating How Patient Engagement Gets Done: Patients as Partners in Clinical Research 2024 Recap
How Regeneron Is Applying Innovation to Modernize Clinical Trials
How Regeneron Is Applying Innovation to Modernize Clinical Trials
When Immunotherapy Offers the Chance for Life and Family After Cancer Diagnosis
When Immunotherapy Offers the Chance for Life and Family After Cancer Diagnosis
Medical PTSD and What Clinical Trial Executives Should Know
Medical PTSD and What Clinical Trial Executives Should Know

Biotech CMO/R&D Leadership

View All
A Four-Time CMO on Career Development Advice
A Four-Time CMO on Career Development Advice
Embracing the Role of the CMO at a Commercial-Stage Biotech
Embracing the Role of the CMO at a Commercial-Stage Biotech
What CMOs Need to Know about the Pharma Partnership Diligence Process
What CMOs Need to Know about the Pharma Partnership Diligence Process
How CMOs Can Determine if the Company and C-Suite is a Fit
How CMOs Can Determine if the Company and C-Suite is a Fit

CRAACO: Clinical Research as a Care Option

View All
Moffitt Cancer Center CEO Dr Patrick Hwu on CAR T, TILs and Tracking Patient Outcomes
Moffitt Cancer Center CEO Dr Patrick Hwu on CAR T, TILs and Tracking Patient Outcomes
Montefiore Einstein Brings Early Phase Clinical Research to an Under-Resourced Patient Population
Montefiore Einstein Brings Early Phase Clinical Research to an Under-Resourced Patient Population
An App that Remotely Monitors Immunotherapy Patients and Informs Clinical Research, at MD Anderson Cancer Center
An App that Remotely Monitors Immunotherapy Patients and Informs Clinical Research, at MD Anderson Cancer Center
How MIT Developed Invisible Remote Monitoring to Enhance Research
How MIT Developed Invisible Remote Monitoring to Enhance Research

Women Leadership in Biotech

View All
Women Leadership in Immuno-Oncology: 2020 Celebration Series
Women Leadership in Immuno-Oncology: 2020 Celebration Series
Women Leadership in Immuno-Oncology: 2022 Celebration Series
Women Leadership in Immuno-Oncology: 2022 Celebration Series
Women Leadership in Immuno-Oncology: 2021 Celebration Series
Women Leadership in Immuno-Oncology: 2021 Celebration Series
Women Leadership in Drug Delivery Celebration Series
Women Leadership in Drug Delivery Celebration Series

Subscribe for More Information

Please provide your contact information and select areas of interest to receive updates.